Screener
Axogen AXGN Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.
The source filing: Axogen’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:24 PM EST
- Fiscal year
- FY2025
- Accession
- 0000805928-26-000031
| Line item | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Provision for (recovery of) bad debts | 400 | 650 | (271) |
| Investment gains, net | (329) | (155) | (666) |
| Change in fair value of debt derivative liabilities | 1,487 | (587) | (1,531) |
| Impairment of long-lived assets | 64 | — | — |
| Stock-based compensation expense | 30,112 | 15,906 | 14,418 |
| Change in operating assets and liabilities: | |||
| Accounts receivable | (2,464) | 392 | (2,691) |
| Inventory | (9,190) | (10,163) | (4,115) |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Axogen's impairment charges?
- Axogen (AXGN) reported impairment charges of $16K in Q4 2025.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Axogen's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude